Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial (Q30858811)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
scientific article

    Statements

    Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial (English)
    1 reference
    0 references
    Patrick Ndase
    1 reference
    Katherine K Thomas
    1 reference
    James D Campbell
    1 reference
    Jonathan Wangisi
    1 reference
    Kenneth H Fife
    1 reference
    James Kiarie
    1 reference
    Craig Hendrix
    1 reference
    Mark A Marzinke
    1 reference
    David Bangsberg
    1 reference
    Partners PrEP Study Team
    1 reference
    7 October 2014
    1 reference
    14
    1 reference
    1055-1064
    1 reference
    11
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit